scholarly journals Acceptability of HIV Vaccine - Efficacy Trials in Drug Users and Sexual Partners of HIV Infected Patients in Barcelona, Spain

10.5772/23977 ◽  
2011 ◽  
Author(s):  
Arantza Sanvisens ◽  
Inmaculada Rivas ◽  
Rosa Guerola ◽  
Patricia Cobarsi ◽  
Rayen Rall ◽  
...  
Keyword(s):  
Vaccine Efficacy ◽  
Drug Users ◽  
Sexual Partners ◽  
Hiv Vaccine ◽  
Efficacy Trials

Will Preventive HIV Vaccine Efficacy Trials Be Possible With Female Injection Drug Users?

1995 ◽  
Vol 10 (5) ◽  
pp. 577-585 ◽  
Author(s):  
Kathleen Meyers ◽  
David S. Metzger ◽  
Thomas A. McLellan ◽  
Helen Navaline ◽  
Amy R. Sheon ◽  
...  
Keyword(s):  
Vaccine Efficacy ◽  
Injection Drug Users ◽  
Drug Users ◽  
Hiv Vaccine ◽  
Injection Drug ◽  
Efficacy Trials

scholarly journals What motivates or demotivates intravenous drug users to participate in hypothetical HIV vaccine efficacy trial? A qualitative study from urban Tanzania

2020 ◽  
Vol 4 (2) ◽  
pp. 128-139
Author(s):  
Masunga K Iseselo ◽  
Edith AM Tarimo ◽  
Eric Sandstrom ◽  
Asli Kulane
Keyword(s):  
Low Income ◽  
Vaccine Efficacy ◽  
Drug Users ◽  
Vaccine Trial ◽  
Sampling Technique ◽  
Hiv Vaccine ◽  
Low Income Countries ◽  
Hiv Vaccine Trials ◽  
Efficacy Trials ◽  
Vaccine Trials

Background: HIV vaccine efficacy trials require the active participation of volunteers who are committed and adherent to the study protocol. However, information about the influence of Injecting Drug Users (IDUs) to participate in HIV vaccine efficacy trials in low-income countries is inadequate. The present study explored the factors that motivate or hinder IDUs from participating in HIV vaccine efficacy trials in Dar es Salaam, Tanzania. Methods: A qualitative descriptive study design was employed among IDUs at Muhimbili National Hospital (MNH). A purposeful sampling technique was used to recruit the participants. Three (3) focus group discussions (FGDs) and 10 In-Depth Interviews (IDIs) were used to collect the data. The data from participants were audio-recorded, transcribed, and analysed using the content analysis approach. Findings: The participants reported that altruism and the desire to reduce risks of HIV infection were the motivators to participate in hypothetical HIV vaccine trials. In addition, participants reported to consult close relatives towards motivation to participate in the vaccine trial. In contrast, the perceived fear of vaccine side effects, lack of information about HIV vaccine studies, and HIV-related stigma towards participants were described as barriers to participate in the HIV vaccine trials. Conclusion: Participation in a hypothetical HIV vaccine trial among IDUs is influenced by positive and negative factors. Actual recruitment plans could be made through a better explanation of HIV vaccine trials, the expected individual and collective benefits associated with the trials. Community involvement and sensitisation is likely to enhance participation in future HIV vaccine trials in Tanzania.

Will Preventive HIV Vaccine Efficacy Trials Be Possible With Female Injection Drug Users?

1995 ◽  
Vol 10 (5) ◽  
pp. 577-585 ◽  
Author(s):  
Kathleen Meyers ◽  
David S. Metzger ◽  
Thomas A. McLellan ◽  
Helen Navaline ◽  
Amy R. Sheon ◽  
...  
Keyword(s):  
Vaccine Efficacy ◽  
Injection Drug Users ◽  
Drug Users ◽  
Hiv Vaccine ◽  
Injection Drug ◽  
Efficacy Trials

scholarly journals The feasibility of HIV vaccine efficacy trials among Russian injection drug users

Vaccine ◽  
2007 ◽  
Vol 25 (41) ◽  
pp. 7014-7016 ◽  
Author(s):  
Chris Beyrer ◽  
Stefan Baral ◽  
Alla Shaboltas ◽  
Elena Dukhovlinova ◽  
Alexey Masharsky ◽  
...  
Keyword(s):  
Vaccine Efficacy ◽  
Injection Drug Users ◽  
Drug Users ◽  
Hiv Vaccine ◽  
Injection Drug ◽  
Efficacy Trials

Preparation for HIV Vaccine Efficacy Trials

2015 ◽  
pp. 155-160 ◽  
Author(s):  
Rodney Hoff ◽  
Dale N. Lawrence
Keyword(s):  
Vaccine Efficacy ◽  
Hiv Vaccine ◽  
Efficacy Trials

scholarly journals Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda

Vaccine ◽  
2013 ◽  
Vol 31 (44) ◽  
pp. 5055-5061 ◽  
Author(s):  
Gershim Asiki ◽  
Andrew Abaasa ◽  
Eugene Ruzagira ◽  
Freddie Kibengo ◽  
Ubaldo Bahemuka ◽  
...  
Keyword(s):  
High Risk ◽  
Vaccine Efficacy ◽  
Lake Victoria ◽  
Hiv Vaccine ◽  
Fishing Communities ◽  
Willingness To Participate ◽  
Men And Women ◽  
Efficacy Trials

scholarly journals Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda

Retrovirology ◽  
2012 ◽  
Vol 9 (S2) ◽  
Author(s):  
A Nanvubya ◽  
J Mpendo ◽  
A Ssetaala ◽  
W Kidega ◽  
S Sigirenda ◽  
...  
Keyword(s):  
Vaccine Efficacy ◽  
Hiv Vaccine ◽  
Fishing Communities ◽  
Willingness To Participate ◽  
Efficacy Trials

Identification of a High-Risk Heterosexual Cohort for HIV Vaccine Efficacy Trials in Rio de Janeiro, Brazil, Using a Sensitive/Less-Sensitive Assay: An Update

2004 ◽  
Vol 36 (3) ◽  
pp. 880-881 ◽  
Author(s):  
Paulo Feijó Barroso ◽  
Lee H. Harrison ◽  
Maria de Fátima Melo ◽  
Sônia Maria Batista ◽  
Marilene da Silva Bastos ◽  
...  
Keyword(s):  
High Risk ◽  
Vaccine Efficacy ◽  
Rio De Janeiro ◽  
Hiv Vaccine ◽  
Sensitive Assay ◽  
Efficacy Trials
Sign in / Sign up

Export Citation Format

Share Document